Search results
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 2 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their...
The Motley Fool· 6 days agoAre you famous enough for picking great stocks to become a billionaire money manager? The U.S....
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 4 days agoThis is a 28% discount to its average forward-year multiple over the last five years, and one heck...
The West should be on a war footing for the next pandemic
The Telegraph via Yahoo News· 3 days agoPeople have been quick to forget how bad the pandemic was, but it’s important to remember the scale...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 3 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19 pandemic in the ...
Uncover the Hidden Data on This Medical Procedure in Children
Mercola· 3 days ago“They do not publish the results [or] let any independent scientist in to look at that information,” Brian Hooker, chief scientific officer for Children’s Health Defense, said. In 1962, children received just five vaccine doses.
6 Safe Blue Chip Dividend Stocks That Yield More Than Treasury Bonds
247wallst.com· 5 days agoSince 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital ...
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace· 5 days agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. Companies with a strong reputation and...
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
Fortune· 4 days agoThe company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end of the decade to meet the new total revenue target, Astra said Tuesday. The revenue goal ...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 5 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
